Tumor-suppressor genes: news about the interferon connection.

AUTOR(ES)

Lengyel, P

RESUMO

The interferons are a family of secreted, multifunctional proteins which are components of the defenses of vertebrates against viral, bacterial, and parasitic infections and certain tumors. They exert their various activities by inducing the synthesis of a large variety of proteins. There are direct and indirect indications that several of these proteins may have tumor-suppressor activities. The interferon-inducible proteins implicated include: (i) a double-stranded RNA-activatable protein kinase that can phosphorylate and thereby inactivate the eukaryotic peptide chain initiation factor eIF-2; (ii) the interferon regulatory factors IRF-1 and IRF-2, which can modulate the expression of the interferons and of some interferon-inducible proteins; and (iii) RNase L, a latent endoribonuclease which can be activated by (2'-5')oligoadenylates, the products of a family of enzymes which are also interferon-inducible. It is note-worthy that some of the proteins encoded by tumor virus oncogenes (e.g., E1A from adenovirus, EBNA-2 from Epstein-Barr virus, and terminal protein from hepatitis B virus) impair the induction of at least some proteins by interferons.

Documentos Relacionados

• Positive selection of candidate tumor-suppressor genes by subtractive hybridization.
• The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region
• Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
• The Hippo tumor-suppressor pathway regulates apical-domain size in parallel to tissue growth
• Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.